UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 31, 2005
-------------
ROCKWELL MEDICAL TECHNOLOGIES, INC.
-----------------------------------
(Exact name of registrant as specified in its Charter)
Michigan 000-230-661 38-3317208
---------------------------- ----------- ----------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
30142 Wixom Road, Michigan 48334
----------------- -------- -----
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (248) 960-9009
----------------
Not applicable
-----------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
/ / Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
/ / Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR
240.14a-12)
/ / Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
/ / Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF PRINCIPAL OFFICER.
(d) On July 31, 2005, the board of directors of Rockwell Medical
Technologies, Inc. ("Rockwell") elected Patrick J. Bagley as a new director of
Rockwell. Mr. Bagley also has been appointed by Rockwell's board of directors
to serve on Rockwell's audit and compensation committees.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ROCKWELL MEDICAL TECHNOLOGIES, INC.
Date: August 4, 2005 By: /s/ Robert L. Chioini
--------------------------------------
Robert L. Chioini
President and Chief Executive Officer
3